Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China flag China · Delayed Price · Currency is CNY
7.27
-0.15 (-2.02%)
At close: Feb 13, 2026

SHA:600223 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,7512,9481,7344,3185,1395,074
Cash & Short-Term Investments
2,7512,9481,7344,3185,1395,074
Cash Growth
-6.54%70.04%-59.85%-15.97%1.27%34.82%
Accounts Receivable
540.45511.85599.06428.31306.23447.69
Other Receivables
33.9121.223,0521,3071,226400.42
Receivables
574.36533.073,6521,7401,532848.11
Inventory
483.18558.71525.4446,04748,20446,665
Prepaid Expenses
---491.91608.15449.64
Other Current Assets
159.5510473.853,0323,1876,080
Total Current Assets
3,9684,1445,98455,62958,67059,117
Property, Plant & Equipment
1,1791,1921,2031,3821,3451,201
Long-Term Investments
185.31168.53191.76926.97874.1633.52
Goodwill
153.74153.74153.74155.59160.33164.31
Other Intangible Assets
163.83163.22148.7196.5210.1215.7
Long-Term Deferred Tax Assets
28.2629.8223.66105.04101.25105.42
Long-Term Deferred Charges
83.591.1153.9652.3440.5144.1
Other Long-Term Assets
68.8758.7358.2626.2213.9217.53
Total Assets
5,8316,0007,81858,47461,41561,499
Accounts Payable
312.06413.35452.989,2668,6948,388
Accrued Expenses
53.71136.53127.321,003948.47727.27
Short-Term Debt
181.06212.12705.222,2703,2194,303
Current Portion of Long-Term Debt
10.9312.51790.343,2222,3072,738
Current Portion of Leases
-9.218.165.681.99-
Current Income Taxes Payable
26.1516.359.5226.5918.8195.91
Current Unearned Revenue
91.41122.97108.4417,86921,68618,561
Other Current Liabilities
204.34183.3199.7816,94414,21715,673
Total Current Liabilities
879.661,1062,40250,60651,09350,486
Long-Term Debt
-44.55665.042,2153,7514,427
Long-Term Leases
8.087.5312.9821.377.69-
Long-Term Unearned Revenue
52.4751.2355.1855.6359.1753.45
Long-Term Deferred Tax Liabilities
22.312.738.555.246.54
Other Long-Term Liabilities
-----7.95
Total Liabilities
942.211,2123,13852,90754,91654,981
Common Stock
1,0171,0171,0171,0171,0091,009
Additional Paid-In Capital
614.02612.86612.51617.8616.3840.68
Retained Earnings
2,5562,4752,3852,0822,2022,130
Comprehensive Income & Other
--0.290.33900900
Total Common Equity
4,1874,1054,0153,7174,7274,080
Minority Interest
702.18683.47665.371,8501,7732,437
Shareholders' Equity
4,8894,7884,6805,5676,5006,517
Total Liabilities & Equity
5,8316,0007,81858,47461,41561,499
Total Debt
200.07285.922,1827,7359,28711,468
Net Cash (Debt)
2,5512,662-448.16-3,417-4,149-6,394
Net Cash Per Share
2.502.62-0.44-3.01-4.01-6.31
Filing Date Shares Outstanding
1,0171,0171,0171,0171,0091,009
Total Common Shares Outstanding
1,0171,0171,0171,0171,0091,009
Working Capital
3,0893,0373,5835,0237,5778,631
Book Value Per Share
4.124.043.953.663.793.15
Tangible Book Value
3,8693,7883,7123,3654,3573,700
Tangible Book Value Per Share
3.813.733.653.313.432.77
Buildings
-1,0459171,3121,2941,009
Machinery
-681.06620.81604.52551.66436.84
Construction In Progress
-16.12131.3672.9540.99247.05
Source: S&P Global Market Intelligence. Standard template. Financial Sources.